Total Payments
$9,951
2023 Payments
$196.26
Companies
5
Transactions
40
Medicare Patients
4,542
Medicare Billing
$591,136
Payment Breakdown by Category
Consulting$6,760 (67.9%)
Travel$1,386 (13.9%)
Food & Beverage$1,141 (11.5%)
Other$664.00 (6.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,760 | 2 | 67.9% |
| Travel and Lodging | $1,386 | 7 | 13.9% |
| Food and Beverage | $1,141 | 30 | 11.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $664.00 | 1 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $5,002 | 4 | $0 (2019) |
| Gilead Sciences, Inc. | $4,249 | 33 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $664.00 | 1 | $0 (2018) |
| PENTAX of America, Inc. | $22.09 | 1 | $0 (2022) |
| AbbVie, Inc. | $13.66 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $196.26 | 2 | Gilead Sciences, Inc. ($196.26) |
| 2022 | $113.85 | 2 | Gilead Sciences, Inc. ($91.76) |
| 2021 | $61.58 | 4 | Gilead Sciences, Inc. ($61.58) |
| 2019 | $5,118 | 7 | PFIZER INC. ($5,002) |
| 2018 | $4,192 | 15 | Gilead Sciences, Inc. ($3,514) |
| 2017 | $269.53 | 10 | Gilead Sciences Inc ($269.53) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $71.27 | General |
| 03/08/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: HBV | ||||||
| 05/19/2022 | PENTAX of America, Inc. | C2 CryoBalloon (Device) | Food and Beverage | Cash or cash equivalent | $22.09 | General |
| Category: Gastroenterology | ||||||
| 03/03/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $91.76 | General |
| 05/03/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.14 | General |
| 04/21/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.97 | General |
| 04/08/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.25 | General |
| 03/11/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 10/01/2019 | PFIZER INC. | XELJANZ (Drug) | Travel and Lodging | In-kind items and services | $207.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/23/2019 | PFIZER INC. | XELJANZ (Drug) | Consulting Fee | Cash or cash equivalent | $4,410.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/07/2019 | PFIZER INC. | XELJANZ (Drug) | Travel and Lodging | In-kind items and services | $196.97 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/07/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $187.07 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/28/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $1.37 | General |
| 06/27/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $106.29 | General |
| 02/04/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.39 | General |
| 08/31/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 08/24/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.71 | General |
| 06/26/2018 | Otsuka America Pharmaceutical, Inc. | BREATHTEK (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $664.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/11/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.78 | General |
| 06/09/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Consulting Fee | Cash or cash equivalent | $2,350.00 | General |
| Category: HBV | ||||||
| 06/09/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $460.41 | General |
| Category: HBV | ||||||
| 06/09/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $265.37 | General |
| Category: HBV | ||||||
| 06/09/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $153.00 | General |
| Category: HBV | ||||||
| 06/09/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $67.58 | General |
| Category: HBV | ||||||
| 06/09/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: HBV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,124 | 1,257 | $1.2M | $147,112 |
| 2022 | 14 | 1,187 | 1,348 | $1.3M | $166,396 |
| 2021 | 17 | 1,252 | 1,340 | $1.4M | $166,306 |
| 2020 | 14 | 979 | 1,081 | $957,544 | $111,322 |
Total Patients
4,542
Total Services
5,026
Medicare Billing
$591,136
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 178 | 182 | $452,352 | $43,870 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 283 | $103,012 | $31,569 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 152 | $37,544 | $12,569 | 33.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 154 | 156 | $236,967 | $11,791 | 5.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 132 | 140 | $169,404 | $11,263 | 6.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $37,118 | $9,726 | 26.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 61 | $42,944 | $8,889 | 20.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 32 | 32 | $48,448 | $6,750 | 13.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $24,139 | $2,665 | 11.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $5,868 | $2,022 | 34.5% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 14 | 15 | $2,265 | $1,655 | 73.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 11 | 13 | $10,488 | $1,611 | 15.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $14,863 | $1,147 | 7.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $4,380 | $1,095 | 25.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 103 | 104 | $24,752 | $489.99 | 2.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 263 | 403 | $142,259 | $47,111 | 33.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 183 | 185 | $446,089 | $42,912 | 9.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 71 | 74 | $51,060 | $13,345 | 26.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 145 | 149 | $182,823 | $13,212 | 7.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 13 | 13 | $60,879 | $11,353 | 18.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 146 | 146 | $216,365 | $11,038 | 5.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $33,356 | $8,812 | 26.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 30 | 30 | $43,470 | $6,161 | 14.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 41 | $9,840 | $3,037 | 30.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $17,388 | $2,453 | 14.1% |
About Edward Huang, MD, MPH
Edward Huang, MD, MPH is a Internal Medicine healthcare provider based in Mountain View, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275682650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edward Huang, MD, MPH has received a total of $9,951 in payments from pharmaceutical and medical device companies, with $196.26 received in 2023. These payments were reported across 40 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($6,760).
As a Medicare-enrolled provider, Huang has provided services to 4,542 Medicare beneficiaries, totaling 5,026 services with total Medicare billing of $591,136. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Mountain View, CA
- Active Since 01/09/2007
- Last Updated 12/12/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275682650
Products in Payments
- XELJANZ (Drug) $5,002
- Vemlidy (Drug) $3,802
- BREATHTEK (Device) $664.00
- C2 CryoBalloon (Device) $22.09
- Humira (Biological) $13.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mountain View
Mr. Kenneth Peters, Md, MD
Internal Medicine — Payments: $111,214
Internal Medicine $111,214
Stephanie Wong, Md, MD
Internal Medicine — Payments: $23,168
Internal Medicine $23,168
Mr. Lawrence Epstein, Md, MD
Internal Medicine — Payments: $15,464
Internal Medicine $15,464
Sanjeev Tummala, Md, MD
Internal Medicine — Payments: $15,128
Internal Medicine $15,128
Joseph Chao, M.d, M.D
Internal Medicine — Payments: $14,752
Internal Medicine $14,752
Dr. Suneetha Maddineni, M.d, M.D
Internal Medicine — Payments: $13,762
Internal Medicine $13,762